Literature DB >> 5772519

Physical properties of the skin in the Ehlers-Danlos syndrome.

R Grahame, P Beighton.   

Abstract

Entities:  

Mesh:

Year:  1969        PMID: 5772519      PMCID: PMC1031172          DOI: 10.1136/ard.28.3.246

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  The structure of the connective tissue, an explanation of the symptoms of the Ehlers-Danlos syndrome.

Authors:  L H JANSEN
Journal:  Dermatologica       Date:  1955-02

2.  The Ehlers-Danlos syndrome; a review of the literature and report of a case with a subgaleal hematoma and Bell's palsy.

Authors:  G K SUMMER
Journal:  AMA J Dis Child       Date:  1956-05

3.  The Harpenden skinfold caliper.

Authors:  J M TANNER; R H WHITEHOUSE
Journal:  Am J Phys Anthropol       Date:  1955-12       Impact factor: 2.868

4.  The fibrous structure of normal and abnormal human skin.

Authors:  R E TUNBRIDGE; R N TATTERSALL; D A HALL; W T ASTBURY; R REED
Journal:  Clin Sci       Date:  1952-11       Impact factor: 6.124

5.  Ehlers-Danlos syndrome associated with the tetralogy of Fallot.

Authors:  E A WALLACH; E F BURKHART
Journal:  Arch Derm Syphilol       Date:  1950-05

6.  X-linked recessive inheritance in the Ehlers-Danlos syndrome.

Authors:  P Beighton
Journal:  Br Med J       Date:  1968-08-17

7.  The influence of ageing on the in vivo elasticity of human skin.

Authors:  R Grahame; P J Holt
Journal:  Gerontologia       Date:  1969

8.  [The Ehlers-Danlos syndrome].

Authors:  B Duperrat
Journal:  Gaz Med Fr       Date:  1965-12-10
  8 in total
  11 in total

1.  Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).

Authors:  U Schwarze; M Atkinson; G G Hoffman; D S Greenspan; P H Byers
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

Review 2.  The Ehlers-Danlos syndrome: on beyond collagens.

Authors:  J R Mao; J Bristow
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Survey of joint mobility and in vivo skin elasticity in London schoolchildren.

Authors:  S Silverman; L Constine; W Harvey; R Grahame
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

4.  Proceedings: Survey of joint mobility and in vivo skin elasticity in London school children.

Authors:  S Silverman; L Constine; W Harvey; R Grahame
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

5.  Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events.

Authors:  John W Petersen; J Yellowlees Douglas
Journal:  Med Hypotheses       Date:  2013-07-03       Impact factor: 1.538

6.  Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.

Authors:  Arick C Park; Charlotte L Phillips; Ferris M Pfeiffer; Drew A Roenneburg; John F Kernien; Sheila M Adams; Jeffrey M Davidson; David E Birk; Daniel S Greenspan
Journal:  Am J Pathol       Date:  2015-05-16       Impact factor: 4.307

Review 7.  Arachnodactyly--a key to diagnosing heritable disorders of connective tissue.

Authors:  Rodney Grahame; Alan J Hakim
Journal:  Nat Rev Rheumatol       Date:  2013-03-12       Impact factor: 20.543

8.  A clinical and echocardiographic study of patients with the hypermobility syndrome.

Authors:  R Grahame; J C Edwards; D Pitcher; A Gabell; W Harvey
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

9.  Upper airway obstruction in a patient with Ehlers-Danlos syndrome.

Authors:  D Chatzoudis; T J Kelly; J Lancaster; T M Jones
Journal:  Ann R Coll Surg Engl       Date:  2015-04       Impact factor: 1.891

10.  Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations.

Authors:  Marco Castori
Journal:  ISRN Dermatol       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.